Some view skyrocketing biotech stocks as a bubble, but hedge funds are riding optimism in the sector to monster gains—for now.» Read More
The Affordable Care Act will add $273.6 billion in insurance administrative overhead costs from 2012 to 2022, a new report says.
Cowen's David Seaburg has a very interesting way to play biotech and pharma stocks now.
Jawbone is suing Fitbit and a group of employees who quit Jawbone, saying they stole trade secrets, business plans, and market research.
The Pentagon said a military facility that mistakenly anthrax to nine states had been trying to develop a test to identify biological threats.
The FBI is looking into what Johnson & Johnson knew about the risks posed by a surgical tool, according to a report by the WSJ.
The first report from a big public-private project to improve genetic testing reveals it is not as rock solid as many people believe.
The White House called for further review from the scientific community on human genome editing in a note issued Tuesday.
Worried about having too many drinks on a work night? A study suggests that this isn’t such a big deal for your productivity, but rather sleep.
In the world's fight against antibiotic resistance, Bayer CEO Marijn Dekkers sees the need for a global antibiotics bailout.
Jawbone, one of Fitbit's wearable health rivals, alleges that ex-employees took confidential data before leaving. NYT reports.
Economists can't figure out what's behind a major spike in medical care prices seen in April, or whether it will last.
Florida faces a budget hole as the Obama administration refuses to give the state all the money it wants for uncompensated hospital costs.
Actavis cannot pull its top-selling Alzheimer's drug from the market in favor of a pricier version, a federal appeals court ruled.
A salmonella outbreak likely linked to raw tuna has sickened 53 people in nine states, health officials said Thursday.
More than 40 percent of people with individual health plans say it is very or somewhat difficult to pay their premiums.
Myndlift is a tech start-up combining mobile gaming with neurofeedback monitoring as an alternative to the surge in ADHD drug prescriptions.
Seventy percent of women who sought fertility treatments went into debt, according to a new study.
Cheaper biotech drugs are headed to the U.S., but analyst Mike Weinstein thinks J&J can manage through some of the challenges.
Deductibles have become a bigger factor in cases of people having insurance but being financially strained.
Drugstore operator CVS Health said it will acquire pharmacy service provider Omnicare for an enterprise value of about $12.7 billion.
Get the best of CNBC in your inbox